Net profit of Shalby rose 24.72% to Rs 19.07 crore in the quarter ended December 2023 as against Rs 15.29 crore during the previous quarter ended December 2022. Sales rose 6.71% to Rs 216.05 crore in the quarter ended December 2023 as against Rs 202.46 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales216.05202.46 7 OPM %19.5916.70 - PBDT43.2135.33 22 PBT30.8123.54 31 NP19.0715.29 25 Powered by Capital Market - Live News

Shalby will hold a meeting of the Board of Directors of the Company on 7 February 2024.Powered by Capital Market - Live News

Shalby announced that the Board of Directors of Company�fs Wholly�]owned Subsidiary Mars Medical Devices (MMDL) has, at its meeting held today i.e. 18 December 2023 approved to invest 2,00,000 Preference Shares of SGD 1 each in Shalby Global Technologies, Singapore (SGTPL).SGTPL is a subsidiary of Mars Medical Devices and a Step�]down Subsidiary of the Company. With the aforesaid investment, preference shareholding of MMDL in SGTPL will be 100% and there will not beany change in equity shareholding and remained at 99.33%. Powered by Capital Market - Live News

Shalby announced that Sushobhan Dasputa, Vice Chairman andGlobal President (Non�]Executive Director) (DIN: 06381955) of the company will be retiring on account of Superannuation on 31 January 2024. Powered by Capital Market - Live News

Net profit of Shalby rose 49.81% to Rs 27.58 crore in the quarter ended September 2023 as against Rs 18.41 crore during the previous quarter ended September 2022. Sales rose 17.93% to Rs 237.98 crore in the quarter ended September 2023 as against Rs 201.80 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales237.98201.80 18 OPM %22.1518.37 - PBDT54.9340.59 35 PBT42.6328.69 49 NP27.5818.41 50 Powered by Capital Market - Live News